Literature DB >> 21204826

STEP regulation of seizure thresholds in the hippocampus.

Stephen W Briggs1, Jeffrey Walker, Kemal Asik, Paul Lombroso, Janice Naegele, Gloster Aaron.   

Abstract

PURPOSE: To investigate whether striatal enriched protein tyrosine phosphatase (STEP) influences ictogenesis.
METHODS: STEP knockout mice were compared to wild-type (WT) mice in pilocarpine-induced seizures. Hippocampal slices were also prepared from these two mouse populations, allowing the examination of ictal-like stimulation in these slices using calcium imaging and electrophysiologic recordings. KEY
FINDINGS: To examine seizure thresholds, increasing doses of pilocarpine were administered to adult mice and seizures were scored behaviorally. Significantly fewer STEP knockout mice developed seizures that progressed to the stage of status epilepticus compared to WT mice. To examine potential differences in neural circuits that might account for this finding, seizure-like activity was induced in hippocampal slices. Electrical stimulation of the hippocampal-entorhinal cortex pathway in STEP knockout mice resulted in less activation of the dentate gyrus granule cell layer (GCL), but greater activation of the hilus in STEP knockouts, compared with heterozygous slices. SIGNIFICANCE: STEP deficiency is associated with higher seizure thresholds. The locus of these effects appears to include the dentate gyrus granule cell layer and hilus. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204826      PMCID: PMC3058409          DOI: 10.1111/j.1528-1167.2010.02912.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  42 in total

1.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

2.  Somatostatin depresses long-term potentiation and Ca2+ signaling in mouse dentate gyrus.

Authors:  Michael V Baratta; Tyra Lamp; Melanie K Tallent
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

3.  Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP).

Authors:  Steven P Braithwaite; Michael Adkisson; John Leung; Adrian Nava; Brett Masterson; Roman Urfer; Donna Oksenberg; Karoly Nikolich
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

4.  Detecting action potentials in neuronal populations with calcium imaging.

Authors:  D Smetters; A Majewska; R Yuste
Journal:  Methods       Date:  1999-06       Impact factor: 3.608

5.  A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures.

Authors:  P J Lombroso; J R Naegele; E Sharma; M Lerner
Journal:  J Neurosci       Date:  1993-07       Impact factor: 6.167

6.  The role of STEP in Alzheimer's disease.

Authors:  Pradeep Kurup; Yongfang Zhang; Deepa V Venkitaramani; Jian Xu; Paul J Lombroso
Journal:  Channels (Austin)       Date:  2010-09-06       Impact factor: 2.581

7.  Long-term hyperexcitability in the hippocampus after experimental head trauma.

Authors:  V Santhakumar; A D Ratzliff; J Jeng; Z Toth; I Soltesz
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

8.  Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study.

Authors:  W A Turski; E A Cavalheiro; M Schwarz; S J Czuczwar; Z Kleinrok; L Turski
Journal:  Behav Brain Res       Date:  1983-09       Impact factor: 3.332

9.  Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase.

Authors:  Yun-Sik Choi; Stanley L Lin; Boyoung Lee; Pradeep Kurup; Hee-Yeon Cho; Janice R Naegele; Paul J Lombroso; Karl Obrietan
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

10.  Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy.

Authors:  R S Sloviter
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

View more
  11 in total

1.  Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Authors:  S M Goebel-Goody; E D Wilson-Wallis; S Royston; S M Tagliatela; J R Naegele; P J Lombroso
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

2.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

Review 3.  Taking STEPs forward to understand fragile X syndrome.

Authors:  Susan M Goebel-Goody; Paul J Lombroso
Journal:  Results Probl Cell Differ       Date:  2012

4.  Left Habenular Activity Attenuates Fear Responses in Larval Zebrafish.

Authors:  Erik R Duboué; Elim Hong; Kiara C Eldred; Marnie E Halpern
Journal:  Curr Biol       Date:  2017-07-14       Impact factor: 10.834

5.  Altered Intracellular Calcium Homeostasis Underlying Enhanced Glutamatergic Transmission in Striatal-Enriched Tyrosine Phosphatase (STEP) Knockout Mice.

Authors:  Federica Bosco; Pierluigi Valente; Marco Milanese; Alessandra Piccini; Mirko Messa; Giambattista Bonanno; Paul Lombroso; Pietro Baldelli; Fabio Benfenati; Silvia Giovedì
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

Review 6.  Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders.

Authors:  Susan M Goebel-Goody; Matthew Baum; Constantinos D Paspalas; Stephanie M Fernandez; Niki C Carty; Pradeep Kurup; Paul J Lombroso
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

7.  Pharmacological inhibition of STriatal-Enriched protein tyrosine Phosphatase by TC-2153 reduces hippocampal excitability and seizure propensity.

Authors:  Jennifer M Walters; Eung Chang Kim; Jiaren Zhang; Han Gil Jeong; Archit Bajaj; Brian C Baculis; Gregory C Tracy; Baher Ibrahim; Catherine A Christian-Hinman; Daniel A Llano; Graham R Huesmann; Hee Jung Chung
Journal:  Epilepsia       Date:  2022-02-21       Impact factor: 6.740

Review 8.  Disruption of striatal-enriched protein tyrosine phosphatase (STEP) function in neuropsychiatric disorders.

Authors:  Takatoshi Karasawa; Paul J Lombroso
Journal:  Neurosci Res       Date:  2014-09-10       Impact factor: 3.304

9.  Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase, and homer 1, in autism: a postmortem study in cerebellar vermis and superior frontal cortex.

Authors:  S Hossein Fatemi; Timothy D Folsom; Rachel E Kneeland; Mahtab K Yousefi; Stephanie B Liesch; Paul D Thuras
Journal:  Mol Autism       Date:  2013-06-26       Impact factor: 7.509

10.  Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease.

Authors:  Jian Xu; Manavi Chatterjee; Tyler D Baguley; Jonathan Brouillette; Pradeep Kurup; Debolina Ghosh; Jean Kanyo; Yang Zhang; Kathleen Seyb; Chimezie Ononenyi; Ethan Foscue; George M Anderson; Jodi Gresack; Gregory D Cuny; Marcie A Glicksman; Paul Greengard; TuKiet T Lam; Lutz Tautz; Angus C Nairn; Jonathan A Ellman; Paul J Lombroso
Journal:  PLoS Biol       Date:  2014-08-05       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.